Stockreport

Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure

INTERPACE BIOSCIENCES INC  (IDXG) 
Last interpace biosciences inc earnings: 11/13 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: interpacediagnostics.com/investors
PDF Preliminary 2025 thyroid testing revenue grew 21% over prior year Initial 2026 guidance of 16% growth in thyroid testing revenue All preferred stock converted to comm [Read more]